By Bhanvi Satija LONDON (Reuters) -Swiss drugmaker Novartis is exploring options to add more medicines to its direct-to-patient platform that is expected to launch in the U.S. on November 1, CEO Vas Narasimhan told Reuters in an interview on Tuesday. We're certainly looking to see if we can add other medicines to the platform, Narasimhan said, while cautioning that no...

Overview * Tenet Q3 2025 revenue beats analyst expectations, growing 3.2% yr/yr * Adjusted EPS for Q3 2025 beats consensus, rising 26.3% yr/yr * Company raises FY 2025 Adjusted EBITDA outlook by $50 mln at midpoint Outlook * Tenet raises FY 2025 Adjusted EBITDA outlook to $4.47 bln-$4.57 bln * Company expects FY 2025 net operating revenues of $21.15 bln-$21.35...

06:53 AM EDT, 10/28/2025 (MT Newswires) -- Zebra Technologies ( ZBRA ) reported Q3 non-GAAP earnings Tuesday of $3.88 per diluted share, up from $3.49 a year earlier. Analysts polled by FactSet expected $3.75. Net sales for the quarter ended Sept. 27 were $1.32 billion, compared with $1.26 billion a year earlier. Analysts polled by FactSet expected $1.32 billion. The...

Overview * Asbury Automotive ( ABG ) Q3 revenue grows 13% yr/yr but misses analyst expectations * Adjusted EPS for Q3 beats consensus, rising 13% to $7.17 * Company repurchased 220,500 shares for $50 mln in Q3 Outlook * Company did not provide specific future financial guidance Result Drivers * NEW VEHICLE SALES - New vehicle revenue increased by 17%,...